Home LiteratureArticle Details
PMID: 9041439 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Journal of clinical microbiology ·Vol. 35 ·No. 3 ·1997-03-00 ·Pages 791-5

Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM

Abstract

Two cocktails of digoxigenin-labeled human papillomavirus (HPV) type-specific oligonucleotide probes and an enzyme immunoassay (EIA) were used as a basis to developed a group-specific detection method for 14 high-risk (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) and 6 low-risk (types 6, 11, 40, 42, 43, and 44) HPVs, following a general primer GP5+/bioGP6(+)-mediated PCR. The sensitivity of this high-risk/low-risk (HR/LR) HPV PCR-EIA ranged from 10 to 200 HPV copies, depending on the HPV type. Comparison of HR/LR HPV PCR-EIA with radioactive Southern blot hybridization using a general probe on the same PCR products derived from 417 cytomorphologically abnormal cervical scrapings resulted in an overall agreement of 96% between the two methods. Complete concordance between group-specific HR/LR detection and individual typing results for both single and multiple infections indicate the strong specificity of this HR/LR HPV PCR-EIA. Multiple infections could be predicted by comparing PCR-EIA optical density values of the cocktail probes with one of the individual oligonucleotide probes. This novel HR/LR PCR-EIA allows accurate and rapid identification of high-risk and low-risk HPV types in cervical scrapings and will facilitate HPV detection in HPV mass-screening programs.

MeSH Terms
Base Sequence Cervix Uteri/virology DNA Primers/genetics Female Genotype Humans Immunoenzyme Techniques/statistics & numerical data Mass Screening Papillomaviridae/genetics,isolation & purification,pathogenicity Papillomavirus Infections/complications,virology Polymerase Chain Reaction/methods,statistics & numerical data Risk Factors Sensitivity and Specificity Tumor Virus Infections/complications,virology Uterine Cervical Diseases/complications,virology Uterine Cervical Neoplasms/etiology,prevention & control,virology Virology/methods,statistics & numerical data
Chemicals
DNA Primers
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Jacobs M V
Department of Pathology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Snijders P J
van den Brule A J
Helmerhorst T J
Meijer C J
Walboomers J M
References (24)
24 references, click to expand
  1. [Recommendations in aberrant findings of cytological studies of the cervix uteri].
    Ned Tijdschr Geneeskd. 1987 Sep 19;131(38):1662-3 PMID: 3670461
  2. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.
    J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62 PMID: 9049358
  3. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes.
    J Gen Virol. 1990 Jan;71 ( Pt 1):173-81 PMID: 2154534
  4. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.
    J Clin Microbiol. 1990 Dec;28(12):2739-43 PMID: 2177751
  5. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.
    Obstet Gynecol. 1992 Mar;79(3):328-37 PMID: 1310805
  6. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations.
    J Gen Virol. 1992 Oct;73 ( Pt 10):2653-60 PMID: 1328477
  7. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction.
    Int J Cancer. 1994 Mar 15;56(6):802-6 PMID: 8119769
  8. Human pathogenic papillomavirus types: an update.
    Curr Top Microbiol Immunol. 1994;186:1-12 PMID: 8205835
  9. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.
    Curr Top Microbiol Immunol. 1994;186:131-56 PMID: 8205839
  10. A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors.
    Obstet Gynecol. 1995 Mar;85(3):337-42 PMID: 7862368
  11. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Am J Obstet Gynecol. 1995 Mar;172(3):946-54 PMID: 7892889
  12. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.
    Int J Cancer. 1995 May 4;61(3):306-11 PMID: 7729939
  13. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes.
    J Clin Microbiol. 1995 Apr;33(4):901-5 PMID: 7790457
  14. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
    J Natl Cancer Inst. 1995 Jun 7;87(11):796-802 PMID: 7791229
  15. Human papillomavirus testing in primary cervical screening.
    Lancet. 1995 Jun 17;345(8964):1533-6 PMID: 7791438
  16. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction.
    Br J Cancer. 1995 Aug;72(2):412-7 PMID: 7543772
  17. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.
    J Natl Cancer Inst. 1995 Sep 20;87(18):1365-71 PMID: 7658497
  18. Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay.
    J Clin Microbiol. 1995 Aug;33(8):1973-8 PMID: 7559932
  19. Can papilloma virus testing be used to improve cervical cancer screening?
    Int J Cancer. 1996 Mar 15;65(6):768-73 PMID: 8631589
  20. Screening. The next century.
    Cancer. 1995 Nov 15;76(10 Suppl):1919-27 PMID: 8634983
  21. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR.
    J Med Virol. 1996 Jul;49(3):223-9 PMID: 8818969
  22. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation.
    J Med Virol. 1996 Feb;48(2):161-70 PMID: 8835350
  23. Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay.
    J Virol Methods. 1996 Feb;56(2):231-8 PMID: 8882653
  24. Heterogeneity of the human papillomavirus group.
    J Virol. 1989 Nov;63(11):4898-903 PMID: 2552162
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
1997-03-00
Pages
791-5
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC229677
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com